In a surprising turn of events, lab-grown meat, dairy, and sugar could potentially hit the UK market for human consumption within the next two years. The Food Standards Agency (FSA) is exploring ways to accelerate the approval process for these innovative foods which are cultivated from cells in compact chemical facilities. Despite the UK’s scientific leadership in this field, companies feel hindered by existing regulations that limit their progress.
Last month, the UK witnessed the debut of dog food crafted from lab-grown meat, marking a significant step towards the normalization of such products in the market. Meanwhile, other countries like Singapore, the United States, and Israel have already authorized the sale of cell-cultivated meat for human consumption. To keep up with global competition, the FSA is collaborating with experts from cutting-edge food tech companies and academic researchers to devise new regulations and hasten the approval process.
The UK government, particularly the science minister, Lord Vallance, emphasizes that the regulatory adjustments aim to promote innovation rather than deregulation. Lab-grown foods are produced by cultivating plant or animal tissue from minuscule cells, often involving gene editing to enhance the food’s characteristics. Promoted for their environmental benefits and potential health advantages, these foods are expected to stimulate job creation and economic growth in the UK, which presently lags behind other nations in approval efficiency.
One such company at the forefront of this revolution is Ivy Farm Technologies in Oxford, prepared to introduce lab-grown steaks derived from cells obtained from Wagyu and Aberdeen Angus cows. While the firm submitted an application for steak approval at the start of last year, its CEO, Dr. Harsh Amin, stresses the need for a quicker approval process. Similarly, at Imperial College’s Bezos center in London, Dr. Alicia Graham has uncovered a method to cultivate an alternative to sugar, offering a promising sweetener for fizzy drinks. However, the stringent approval process delays the commercialization of such groundbreaking products, hindering their widespread availability in the UK market
Read the full article from The BBC here: Read More
